Updated: Nov 14, 2019
August National Provider Data Summary
At the end of August 2018, 87.2% of patients waiting to start treatment (incomplete pathways) were waiting up to 18 weeks, thus not meeting the 92% standard.
The number of RTT patients waiting to start treatment at the end of August 2018 was 4.2 million patients. Of those, 3,407 patients were waiting more than 52 weeks.
For patients waiting to start treatment at the end of August 2018, the median waiting time was 7.6 weeks. The 92nd percentile waiting time was 22.1 weeks.
During August 2018, 290,409 RTT patients started admitted treatment and 1,015,697 started non-admitted treatment (completed pathways).
As the below heatmap and graph shows, there has been a substantial deterioration in RTT performance nationally when compared to August 2017.
Waiting List Size
As the below graph demonstrates, from March 2018 to August 2018 the total waiting list size increased from 3,843,182 to 4,154,559, an increase of 311,377 (8.10%).
Below is a table showing each reporting Trusts variance in waiting list size from March 2018 to August 2018, sorted by percentage variance (please click to view the whole table).
52 Week Waiters
The below heatmap shows how the number of 52-week waiters has changed nationally, with some areas such as the South West suffering a significant increase, but other areas such as the East Midlands managing to reduce their number of 52-week waiters.
Below is a table showing each reporting Trust’s variance in 52-week waiters from March 2018 to August 2018, sorted by percentage variance (please click to view the whole table).
Changes to the Individual Specialties
In regard to the waiting list size of the individual specialties:
Thoracic Medicine saw the highest percentage decrease, going from 99,870 to 97,991 a decrease of 1,879 pathways (1.88%), however Other saw the highest decrease in pathways going from 854,241 to 848,525 a decrease of 5,716 pathways (0.66%).
ENT also saw a decrease in the waiting list size going from 303,729 to 301,084, a decrease of 2,645 pathways (0.87%).
Neurology and Neurosurgery both saw a large percentage increase in the waiting list size. Neurology going from 118,837 to 123,121, an increase of 4,284 pathways (3.60%) and Neurosurgery going from 30,060 to 30,933, an increase of 873 pathways (2.90%).
Dermatology, as a single specialty saw the highest percentage increase in the waiting list size as well as the largest increase of pathways, going from 215,630 to 223,746, an increase of 8,116 pathways (3.76%).